Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Topical treatments led to hair regrowth in a man with linear morphea.

Pumpkin seeds may help expel parasites, but findings are retracted.

Apremilast did not work for treating severe alopecia areata.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Air pollution worsens skin diseases and aging by causing inflammation and oxidative stress.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Low vitamin D levels may worsen or cause alopecia areata.

Upadacitinib effectively treats psoriasis and lichen planus together.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Certain bacteria can enhance skin regeneration.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

New treatments offer hope for better managing hidradenitis suppurativa.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Higher leptin levels link to hair loss.